MHRA Class 4 Medicines Notification: Various Products (Zentiva Pharma UK Limited) Date issued: 2 June 2025 Zentiva Pharma UK Limited has informed the MHRA that the batches of soluble or effervescent tablets listed in the annexes are taking longer than expected to fully dissolve, resulting in an increase in residual material being observed. Additionally, some
Read moreThe Department of Health and Social Care (DHSC) has today (30/05/2025) confirmed the following final list of price concessions for May 2025. Drug Pack size Price concession Acetazolamide 250mg tablets 112 £47.22 Cefradine 500mg capsules 20 £13.44 Conjugated oestrogens 1.25mg tablets 84 £52.56 Conjugated oestrogens 300microgram tablets 84 £24.02 Conjugated oestrogens 625microgram tablets 84 £26.87 Duloxetine
Read moreThere is now less than one week to go before the bundling requirements for Pharmacy First come into force, which will impact on whether pharmacy owners are entitled to a monthly fixed payment for the service. From 1st June 2025, pharmacy owners must be registered and able to deliver the Hypertension Case Finding Service*, the
Read moreAhead of negotiations on the Community Pharmacy Contractual Framework (CPCF) for 2026/27 any beyond, Community Pharmacy England is keen to discuss pressing issues and the future of the sector with pharmacy owners and LPCs. All pharmacy owners and their representatives are therefore invited to attend our regional ‘Future of Pharmacy’ workshops to discuss what next
Read moreCommunity Pharmacy England would like to remind pharmacy owners of the requirement to submit their FP34C declaration using the Manage Your Service (MYS) portal and to dispatch any prescription bundles to the relevant pricing division at the NHS Business Services Authority (NHSBSA) no later than the 5th day of the month following that in which
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 June 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Carmellose 1% eye drops 0.4ml unit dose preservative free Celluvisc® 1% eye drops
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 June 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read moreThe Department of Health and Social Care (DHSC) has today (23/05/2025) confirmed the following list of price concessions for May 2025: Drug Pack size Price concession Buprenorphine 2mg sublingual tablets sugar free 7 £2.73 Buprenorphine 8mg sublingual tablets sugar free 7 £10.35 Co-codamol 30mg/500mg effervescent tablets 32 £2.41 Co-codamol 30mg/500mg effervescent tablets 100 £7.52 Codeine 15mg/5ml linctus
Read moreWe are looking for someone who is passionate about community pharmacy and interested in the important work that Local Pharmaceutical Committees (LPCs) do, to join our LPC and Pharmacy Owner Support Team. The team is expanding to include the new post of LPC Engagement and Support Manager, which has been created to enhance the support
Read moreMHRA Class 2 Medicines Notification: Mercaptopurine 50mg Tablets (Aspen Pharma Trading Limited) Drug alert number: EL(25)A/23 Date issued: 22 May 2025 Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a precautionary measure due to microbial contamination following a small number of complaints of discoloured tablets within the packs, identified
Read more
